{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T13:21:36Z","timestamp":1791638496987,"version":"4.3.4"},"reference-count":58,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1016\/j.bcp.2016.08.007","type":"journal-article","created":{"date-parts":[[2016,8,9]],"date-time":"2016-08-09T20:32:51Z","timestamp":1470774771000},"page":"46-56","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":36,"special_numbering":"C","title":["The hybrid molecule, VCP746, is a potent adenosine A2B receptor agonist that stimulates anti-fibrotic signalling"],"prefix":"10.1016","volume":"117","author":[{"given":"Elizabeth A.","family":"Vecchio","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chung Hui","family":"Chuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo-Anne","family":"Baltos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leigh","family":"Ford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter J.","family":"Scammells","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing H.","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arthur","family":"Christopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul J.","family":"White","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren T.","family":"May","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcp.2016.08.007_b0005","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1161\/01.CIR.89.1.151","article-title":"Structural basis of end-stage failure in ischemic cardiomyopathy in humans","volume":"89","author":"Beltrami","year":"1994","journal-title":"Circulation"},{"key":"10.1016\/j.bcp.2016.08.007_b0010","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.cardiores.2006.10.002","article-title":"The role of TGF-beta signaling in myocardial infarction and cardiac remodeling","volume":"74","author":"Bujak","year":"2007","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.bcp.2016.08.007_b0015","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s10741-012-9365-4","article-title":"Fibrosis and heart failure","volume":"19","author":"Segura","year":"2012","journal-title":"Heart Fail. Rev."},{"key":"10.1016\/j.bcp.2016.08.007_b0020","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1093\/cvr\/23.8.655","article-title":"Myocardial stiffness and reparative fibrosis following coronary embolisation in the rat","volume":"23","author":"Carroll","year":"1989","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.bcp.2016.08.007_b0025","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.vph.2012.07.003","article-title":"The role of cardiac fibroblasts in the transition from inflammation to fibrosis following myocardial infarction","volume":"58","author":"van Nieuwenhoven","year":"2013","journal-title":"Vascul. Pharmacol."},{"key":"10.1016\/j.bcp.2016.08.007_b0030","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/j.bbamcr.2012.08.023","article-title":"Fibroblasts in post-infarction inflammation and cardiac repair","volume":"1833","author":"Chen","year":"2013","journal-title":"Biochem. Biophys. Acta"},{"key":"10.1016\/j.bcp.2016.08.007_b0035","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1161\/CIRCRESAHA.113.300268","article-title":"Epidemiology of heart failure","volume":"113","author":"Roger","year":"2013","journal-title":"Circ. Res."},{"key":"10.1016\/j.bcp.2016.08.007_b0040","doi-asserted-by":"crossref","first-page":"477","DOI":"10.2174\/1381612053382098","article-title":"Fibrosis as a therapeutic target post-myocardial infarction","volume":"11","author":"See","year":"2005","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.bcp.2016.08.007_b0045","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1161\/CIRCRESAHA.115.306565","article-title":"Cardiac fibrosis: the fibroblast awakens","volume":"118","author":"Travers","year":"2016","journal-title":"Circ. Res."},{"key":"10.1016\/j.bcp.2016.08.007_b0050","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.pharmthera.2009.05.002","article-title":"Cardiac fibroblasts: at the heart of myocardial remodeling","volume":"123","author":"Porter","year":"2009","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.bcp.2016.08.007_b0055","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1023\/A:1025401026441","article-title":"Modulation of cardiac remodeling by adenosine: in vitro and in vivo effects","volume":"251","author":"Villarreal","year":"2003","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.bcp.2016.08.007_b0060","doi-asserted-by":"crossref","first-page":"H1797","DOI":"10.1152\/ajpheart.00407.2003","article-title":"Acute adenosinergic cardioprotection in ischemic-reperfused hearts","volume":"285","author":"Headrick","year":"2003","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.bcp.2016.08.007_b0065","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/S0031-6997(24)01339-5","article-title":"Adenosine A2B receptors","volume":"49","author":"Feoktistov","year":"1997","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.bcp.2016.08.007_b0070","doi-asserted-by":"crossref","first-page":"C1178","DOI":"10.1152\/ajpcell.00291.2008","article-title":"Regulation of cardiac fibroblast collagen synthesis by adenosine: roles for Epac and PI3K","volume":"296","author":"Villarreal","year":"2009","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"10.1016\/j.bcp.2016.08.007_b0075","doi-asserted-by":"crossref","first-page":"H2478","DOI":"10.1152\/ajpheart.00217.2004","article-title":"Functional effects of enhancing or silencing adenosine A2B receptors in cardiac fibroblasts","volume":"287","author":"Chen","year":"2004","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.bcp.2016.08.007_b0080","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1161\/01.HYP.31.4.943","article-title":"Adenosine inhibits collagen and protein synthesis in cardiac fibroblasts: role of A2B receptors","volume":"31","author":"Dubey","year":"1998","journal-title":"Hypertension"},{"key":"10.1016\/j.bcp.2016.08.007_b0085","doi-asserted-by":"crossref","first-page":"2656","DOI":"10.1161\/01.CIR.96.8.2656","article-title":"Exogenous and endogenous adenosine inhibits fetal calf serum\u2013induced growth of rat cardiac fibroblasts: role of A2B receptors","volume":"96","author":"Dubey","year":"1997","journal-title":"Circulation"},{"key":"10.1016\/j.bcp.2016.08.007_b0090","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1146\/annurev-pharmtox-010611-134514","article-title":"The best of both worlds? Bitopic orthosteric\/allosteric ligands of G protein-coupled receptors","volume":"52","author":"Valant","year":"2012","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.bcp.2016.08.007_b0095","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.tips.2012.10.003","article-title":"Bridging the gap: bitopic ligands of G-protein-coupled receptors","volume":"34","author":"Lane","year":"2013","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.bcp.2016.08.007_b0100","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1111\/fcp.12052","article-title":"Avidity and positive allosteric modulation\/cooperativity act hand in hand to increase the residence time of bivalent receptor ligands","volume":"28","author":"Vauquelin","year":"2013","journal-title":"Fundam. Clin. Pharmacol."},{"key":"10.1016\/j.bcp.2016.08.007_b0105","doi-asserted-by":"crossref","first-page":"4543","DOI":"10.1021\/jm9002582","article-title":"Allosteric modulators of the adenosine A1 receptor: synthesis and pharmacological evaluation of 4-substituted 2-amino-3-benzoylthiophenes","volume":"52","author":"Aurelio","year":"2009","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bcp.2016.08.007_b0110","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.bcp.2015.11.013","article-title":"Quantification of adenosine A1 receptor biased agonism: implications for drug discovery","volume":"99","author":"Baltos","year":"2016","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bcp.2016.08.007_b0115","doi-asserted-by":"crossref","first-page":"4614","DOI":"10.1073\/pnas.1320962111","article-title":"Separation of on-target efficacy from adverse effects through rational design of a bitopic adenosine receptor agonist","volume":"111","author":"Valant","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.bcp.2016.08.007_b0120","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/s11302-015-9460-9","article-title":"Selectivity is species-dependent: characterization of standard agonists and antagonists at human, rat, and mouse adenosine receptors","volume":"11","author":"Alnouri","year":"2015","journal-title":"Purinergic Signal."},{"key":"10.1016\/j.bcp.2016.08.007_b0125","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1124\/jpet.115.230003","article-title":"Ligand-independent adenosine A2B receptor constitutive activity as a promoter of prostate cancer cell proliferation","volume":"357","author":"Vecchio","year":"2016","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.bcp.2016.08.007_b0130","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1006\/jmcc.1998.0717","article-title":"Selective activation of alpha1A-adrenergic receptors in neonatal cardiac myocytes is sufficient to cause hypertrophy and differential regulation of alpha1-adrenergic receptor subtype mRNAs","volume":"30","author":"Autelitano","year":"1998","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.bcp.2016.08.007_b0135","doi-asserted-by":"crossref","first-page":"H1804","DOI":"10.1152\/ajpheart.01078.2007","article-title":"Effects of a Rho kinase inhibitor on pressure overload induced cardiac hypertrophy and associated diastolic dysfunction","volume":"294","author":"Phrommintikul","year":"2008","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.bcp.2016.08.007_b0140","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1124\/mol.107.037630","article-title":"Structure-function studies of allosteric agonism at M2 muscarinic acetylcholine receptors","volume":"72","author":"May","year":"2007","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.bcp.2016.08.007_b0145","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1124\/mol.110.064493","article-title":"The effect of allosteric modulators on the kinetics of agonist-G protein-coupled receptor interactions in single living cells","volume":"78","author":"May","year":"2010","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.bcp.2016.08.007_b0150","doi-asserted-by":"crossref","DOI":"10.1016\/0006-2952(73)90196-2","article-title":"Relationship between the inhibition constant (K i) and the concentration of inhibitor which causes 50 per cent inhibition (I 50) of an enzymatic reaction","author":"Yung-Chi","year":"1973","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bcp.2016.08.007_b0155","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1006\/bulm.1997.0009","article-title":"Parallel dose-response curves in combination experiments","volume":"60","author":"S\u00fchnel","year":"1998","journal-title":"Bull. Math. Biol."},{"key":"10.1016\/j.bcp.2016.08.007_b0160","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1124\/jpet.113.210849","article-title":"BAY60-6583 acts as a partial agonist at adenosine A2B receptors","volume":"349","author":"Hinz","year":"2014","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.bcp.2016.08.007_b0165","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1124\/mol.106.033746","article-title":"A novel multivalent ligand that bridges the allosteric and orthosteric binding sites of the M2 muscarinic receptor","volume":"72","author":"Steinfeld","year":"2007","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.bcp.2016.08.007_b0170","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1002\/cmdc.200600066","article-title":"Improving potency, selectivity, and water solubility of adenosine A1 receptor antagonists: xanthines modified at position 3 and related pyrimido[1,2,3-cd]purinediones","volume":"1","author":"Weyler","year":"2006","journal-title":"ChemMedChem"},{"key":"10.1016\/j.bcp.2016.08.007_b0175","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/S0026-895X(24)12531-X","article-title":"Characterization of human A2B adenosine receptors: radioligand binding, western blotting, and coupling to Gq in human embryonic kidney 293 cells and HMC-1 mast cells","volume":"56","author":"Linden","year":"1999","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.bcp.2016.08.007_b0180","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1172\/JCI117004","article-title":"Stimulation of collagen gene expression and protein synthesis in murine mesangial cells by high glucose is mediated by autocrine activation of transforming growth factor-beta","volume":"93","author":"Ziyadeh","year":"1994","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bcp.2016.08.007_b0185","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1124\/jpet.110.166371","article-title":"Extracellular 3\u2032,5\u2032-cAMP-adenosine pathway inhibits glomerular mesangial cell growth","volume":"333","author":"Dubey","year":"2010","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.bcp.2016.08.007_b0190","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1161\/01.RES.74.4.727","article-title":"Angiotensin II induces fibronectin expression associated with cardiac fibrosis in the rat","volume":"74","author":"Crawford","year":"1994","journal-title":"Circ. Res."},{"key":"10.1016\/j.bcp.2016.08.007_b0195","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1369\/jhc.4A6560.2005","article-title":"Connective tissue growth factor and cardiac fibrosis after myocardial infarction","volume":"53","author":"Dean","year":"2005","journal-title":"J. Histochem. Cytochem."},{"key":"10.1016\/j.bcp.2016.08.007_b0200","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/S0006-2952(00)00570-0","article-title":"Comparison of the potency of adenosine as an agonist at human adenosine receptors expressed in Chinese hamster ovary cells","volume":"61","author":"Fredholm","year":"2001","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bcp.2016.08.007_b0205","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.bcp.2014.05.008","article-title":"Probing biased\/partial agonism at the G protein-coupled A2B adenosine receptor","volume":"90","author":"Gao","year":"2014","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bcp.2016.08.007_b0210","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1038\/nrd746","article-title":"Allosteric binding sites on cell-surface receptors: novel targets for drug discovery","volume":"1","author":"Christopoulos","year":"2002","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.bcp.2016.08.007_b0215","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.2174\/1381612043384303","article-title":"Allosteric modulation of G protein-coupled receptors","volume":"10","author":"May","year":"2004","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.bcp.2016.08.007_b0220","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1038\/nrd3954","article-title":"Signalling bias in new drug discovery: detection, quantification and therapeutic impact","volume":"12","author":"Kenakin","year":"2013","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.bcp.2016.08.007_b0225","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.ceb.2013.10.008","article-title":"Recent developments in biased agonism","volume":"27","author":"Wisler","year":"2014","journal-title":"Curr. Opin. Cell Biol."},{"key":"10.1016\/j.bcp.2016.08.007_b0230","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.tips.2007.06.002","article-title":"GPCR functional selectivity has therapeutic impact","volume":"28","author":"Mailman","year":"2007","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.bcp.2016.08.007_b0235","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1161\/CIRCULATIONAHA.106.630087","article-title":"Long-term stimulation of adenosine A2B receptors begun after myocardial infarction prevents cardiac remodeling in rats","volume":"114","author":"Wakeno","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.bcp.2016.08.007_b0240","doi-asserted-by":"crossref","first-page":"C1171","DOI":"10.1152\/ajpcell.00290.2008","article-title":"Adenosine receptors and second messenger signaling pathways in rat cardiac fibroblasts","volume":"296","author":"Epperson","year":"2009","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"10.1016\/j.bcp.2016.08.007_b0245","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.pharmthera.2013.06.002","article-title":"Cardiovascular adenosine receptors: expression, actions and interactions","volume":"140","author":"Headrick","year":"2013","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.bcp.2016.08.007_b0250","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/S0008-6363(00)00044-4","article-title":"Angiotensin II, adhesion, and cardiac fibrosis","volume":"46","author":"Schnee","year":"2000","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.bcp.2016.08.007_b0255","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1038\/labinvest.2010.190","article-title":"Myocardial fibrosis in response to Angiotensin II is preceded by the recruitment of mesenchymal progenitor cells","volume":"91","author":"Sopel","year":"2010","journal-title":"Lab. Invest."},{"key":"10.1016\/j.bcp.2016.08.007_b0260","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1046\/j.1365-2362.2002.00985.x","article-title":"Myocardial fibrosis in transforming growth factor-beta(1) (TGF-beta(1)) transgenic mice is associated with inhibition of interstitial collagenase","volume":"32","author":"Seeland","year":"2002","journal-title":"Eur. J. Clin. Invest."},{"key":"10.1016\/j.bcp.2016.08.007_b0265","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1006\/jmcc.1996.0185","article-title":"Regulation of proliferative response of cardiac fibroblasts by transforming growth factor-beta 1","volume":"28","author":"Sigel","year":"1996","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.bcp.2016.08.007_b0270","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1161\/CIRCRESAHA.112.278457","article-title":"Cardiorenal syndrome: the emerging role of protein-bound uremic toxins","volume":"111","author":"Lekawanvijit","year":"2012","journal-title":"Circ. Res."},{"key":"10.1016\/j.bcp.2016.08.007_b0275","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1681\/ASN.2011070645","article-title":"EGFR signaling promotes TGF-beta-dependent renal fibrosis","volume":"23","author":"Chen","year":"2012","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.bcp.2016.08.007_b0280","doi-asserted-by":"crossref","first-page":"H1884","DOI":"10.1152\/ajpheart.00967.2011","article-title":"Myocardial infarction impairs renal function, induces renal interstitial fibrosis, and increases renal KIM-1 expression: implications for cardiorenal syndrome","volume":"302","author":"Lekawanvijit","year":"2012","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.bcp.2016.08.007_b0285","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1161\/01.HYP.0000178464.63393.88","article-title":"Adenosine inhibits PDGF-induced growth of human glomerular mesangial cells via A2B receptors","volume":"46","author":"Dubey","year":"2005","journal-title":"Hypertension"},{"key":"10.1016\/j.bcp.2016.08.007_b0290","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1161\/01.RES.0000094744.88220.62","article-title":"Activation of adenosine A1 receptor attenuates cardiac hypertrophy and prevents heart failure in murine left ventricular pressure-overload model","volume":"93","author":"Liao","year":"2003","journal-title":"Circ. Res."}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295216302246?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295216302246?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T12:38:04Z","timestamp":1749040684000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295216302246"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10]]},"references-count":58,"alternative-id":["S0006295216302246"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2016.08.007","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2016,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The hybrid molecule, VCP746, is a potent adenosine A2B receptor agonist that stimulates anti-fibrotic signalling","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2016.08.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}